Waxman/Hatch generic drug law was signed on September 24, 1984 and the new abbreviated pathway for generic drugs quickly became a major source of new work for FDA.

Comprehensive one-stop-shop for generics industry intelligence helps you to make better decisions faster. Intelligence include DMF, NDA, ANDAs with Paragraph IV